BRAF alterations in PXA predominantly include gene fusions and BRAF V600E missense mutations, with BRAF V600E prevalence ranging from 50% to 78% in PXA and 47.4% in anaplastic variants. This evidence concerns the gene BRAF and pleomorphic xanthoastrocytoma.